The Resistoleros are one among many stakeholders HB Fuller should consider when it decides its course of action regarding Resistol. Is it morally permissible for HB Fuller to continue to sell Resistol with its current composition or should Fuller remove the product from the market until an acceptable composition is formulated? What course of action would you recommend to HB Fuller and why?
